Skip to content

Role of Homoeopathic medicines Croton tiglium and Lycopodium clavatum in the treatment of Irritable Bowel Syndrome

Assessing the effectiveness of Homoeopathic Medicines Croton tiglium and Lycopodium clavatum in the treatment of Irritable Bowel Syndrome- An Open Label Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102819
Enrollment
70
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Croton tiglium: To assess the effectiveness of Croton tiglium in the treatment of Irritable Bowel Syndrome Control Intervention1: Lycopodium clavatum: To assess the effectiveness of Lyc

Sponsors

Dr Pralhad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are voluntarily willing to take part in this study and sign the written informed consent Subjects between age group of 21 to 45 years Diagnosed new cases of Irritable Bowel Syndrome using the Rome IV criteria

Exclusion criteria

Exclusion criteria: Subjects having alarming features like anemia, unintended weight loss, nocturnal diarrhea, blood in stool, persistent diarrhea Subjects with systemic illness Subjects with severity scoring system greater than or equal to 300 Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
Recovered-Subjects with complete relief in the clinical symptoms with IBS severity score will be zeroTimepoint: The severity and intensity of the subjects will be assessed using IBS Severity Scoring System on the first visit to determine the baseline score The follow up of the case will be assessed by IBS Severity Scoring System which will be assessed once in 10 days for first 3 months and once in a month for next 3 months

Secondary

MeasureTime frame
Quality of life Timepoint: By the end of 6 months

Countries

India

Contacts

Public ContactDr Pralhad

Government Homoeopathic Medical College and Hospital

pralhadshedole866@gmail.com8660876537

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026